In an ongoing effort to enhance the value of and to further diversify our Technical Program, the Pittcon Organizing Committee is pleased to announce the formation of a Program Resource Team. The purpose of this team is to collaborate on and make recommendations for the 2015 Technical Program. The Team consists of experts in the fields of pharmaceutical science, nanotechnology, and food science.
Professor Alan G. Marshall obtained his Ph.D. from Stanford University. Before joining the faculty at Florida State University, he was a faculty member at the University of British Columbia and at Ohio State University. His recognitions include: Alfred P. Sloan Fellow, American Chemical Society Award in Chemical Instrumentation, Eastern Analytical Symposium Award, American Chemical Society Field-Franklin Award in Mass Spectrometry, Spectroscopy Society of Pittsburgh Maurice F. Hasler Award, New York Society for Applied Spectroscopy Gold Medal, and the American Society for Mass Spectrometry Distinguished Contribution Award.
He is a Fellow of both the American Physical Society and the American Association for the Advancement of Science, and is an FSU Distinguished Research Professor.
Research includes: fourier transform ion cyclotron resonance mass spectrometry, protein structure and folding in solution and gas phase, non-covalent bonding in biological macromolecules, mixture analysis by ultrahigh-resolution mass spectrometry, ultrasensitive mass analysis (at level of a single biological cell), environmental mass spectrometry, and optical spectroscopy of mass-selected trapped ions.
Dr. Chad A. Mirkin is the Director of the International Institute for Nanotechnology, the George B. Rathmann Prof. of Chemistry, Prof. of Chemical and Biological Engineering, Prof. of Biomedical Engineering, Prof. of Materials Science & Engineering, and Prof. of Medicine. He is a chemist and a world renowned nanoscience expert, who is known for his development of nanoparticle-based biodetection and therapeutic schemes, the invention of Dip-Pen Nanolithography and On-Wire Lithography, and contributions to supramolecular chemistry and nanoparticle synthesis. He is the author of over 520 manuscripts and over 900 patent applications worldwide (233 issued), and the founder of four companies, Nanosphere, NanoInk, AuraSense, and AuraSense Therapeutics, which are commercializing nanotechnology applications in the life science and semiconductor industries.
Dr. Mirkin has been recognized for his accomplishments with over 80 national and international awards. He is a Member of the President’s Council of Advisors on Science & Technology (Obama Administration), and the only chemist (one of only 12 scientists, engineers, and medical doctors) to be elected to all three US National Academies (the Inst. of Medicine, the Natl. Academy of Sci., and the Natl. Academy of Engin.). He is also a Fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science and the Materials Research Society. Dr. Mirkin has served on the Editorial Advisory Boards of over twenty scholarly journals.
Dr. Mirkin holds a B.S. degree from Dickinson College (1986, elected into Phi Beta Kappa) and a Ph.D. degree in Chemistry from the Penn. State Univ. (1989). He was an NSF Postdoctoral Fellow at the MIT prior to becoming a professor at Northwestern Univ. in 1991.
Lowri S. De Jager is a Supervisory Research Chemist for the Methods Development Branch in the U.S. Food and Drug Administration’s Center for Food Safety and Applied Nutrition (CFSAN) in College Park, Maryland. The branch’s research focuses on method development for the analysis of additives and contaminants in foods and food packaging. Other work in the branch focuses on investigation of economic adulteration, determination of marine toxins, and method development for food defense.
In addition to her laboratory work, Dr. De Jager serves on various Agency committees and working groups. Dr De Jager received a BSc (Hons) in Chemistry and Biochemistry from Rhodes University and completed her PhD in Chemistry from Ohio University in 2001.
Paul S. Weiss is a distinguished professor of chemistry & biochemistry and of materials science & engineering at the University of California, Los Angeles. He received his S.B. and S.M. degrees in chemistry from MIT in 1980 and his Ph.D. in chemistry from the University of California at Berkeley in 1986. He was a postdoctoral member of technical staff at Bell Laboratories from 1986-88 and a visiting scientist at IBM Almaden Research Center from 1988-89. He served as the director of the California NanoSystems Institute and held the Fred Kavli Chair in NanoSystems Sciences at UCLA from 2009-2014. Before coming to UCLA, he was a distinguished professor of chemistry and physics at the Pennsylvania State University, where he began his academic career in 1989.
His interdisciplinary research group includes chemists, physicists, biologists, materials scientists, mathematicians, electrical and mechanical engineers, and computer scientists. Their work focuses on the ultimate limits of miniaturization, exploring the atomic-scale chemical, physical, optical, mechanical, and electronic properties of surfaces and supramolecular assemblies. He and his students have developed new techniques to expand the applicability and chemical specificity of scanning probe microscopies. They have applied these and other tools to the study of catalysis, self- and directed assembly, and molecular and nanoscale devices. They work to advance nanofabrication down to ever smaller scales and greater chemical specificity in order to operate and to test functional molecular assemblies, and to connect these to the biological and chemical worlds.
Two current major themes in his laboratory are cooperativity in functional molecules and single-molecule biological structural and functional measurements. He has over 300 publications, holds over 20 patents, and has given over 600 invited, plenary, keynote, and named lectures.
Chris is Science Lead for Analytical Chemistry within the Process and Analytical Chemistry area at Merck Research Laboratories in Rahway, NJ. Chris also co-chairs the New Technologies Review and Licensing Committee (NT-RLC), the organization that oversees identification, acquisition and evaluation of new technologies of potential value to Merck Research Laboratories. Chris also co-chairs the newly launched MRL Postdoctoral Research Fellows Program.
Dr. Welch has authored more than 180 scientific publications and patents, and is co-founder of the journal, Enantiomer, a member of the editorial board of the journals, Chirality, Organic & Biomolecular Chemistry, Journal of the Korean Chemical Society, Chemistry World (RSC) and Chemical & Engineering News (ACS). Chris has served as a councilor for the ACS Division of Organic Chemistry since 2007, and was recently elected as chair-elect for this division.
He is a member of the Executive Committee for the International Symposia on Chirality, a member of the ACS steering committee for Pacifichem, and a member of the PittCon Resource Team. Honors and awards include the NJCG Award for Excellence in Chromatography, the PACS Activated Carbon Hall of Fame award, 2009 MRL Presidents Award for Environmental Achievement, Microsoft Life Science Innovation Award (2010) Fellow, American Chemical Society (2010) and Fellow, American Association for the Advancement of Science, AAAS (2013).